Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy

Journal of Cardiovascular Electrophysiology

Volumn 17, Issue 5, 2006, Pages 486-490

  Desai, Aseem D ^a   Burke, Martin C ^a   Hong, Thomas E ^a   Kim, Susan ^a   Salem, Yasser ^a   Yong, Patrick G ^b   Knight, Bradley P ^a,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Cardiac resynchronization therapy; Defibrillation; Heart failure; Implantable cardioverter defibrillator; Pacing; Tachyarrhythmias

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ADULT; AGED; ANAMNESIS; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DATA BASE; DEFIBRILLATOR; DEVICE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SEX RATIO; SYMPTOMATOLOGY; TREATMENT INDICATION;

AGED; ARRHYTHMIA; CARDIAC PACING, ARTIFICIAL; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 33645987941     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00355.x     Document Type: Article

References (16)

1. Bristow MR Saxon LA Boehmer J Kruger S Kass DA DeMarco T Carson P DiCarlo L DeMets D White BG DeVries DW Feldman AM Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 2140 2150.
2. MERIT-HF Study Group Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999 353 2001 07.
3. Gregoratos G Abrams J Epstein AE Freedman RA Hayes DL Hlatky MA Kerber RE Naccarelli GV Schoenfeld MH Silka MJ Winters SL Gibbons RI Antman EM Alpert JS Hiratzka LF Faxon DP Jacobs AK Fuster V Smith SC Jr. American College of Cardiology/American Heart Association Task Force on Practice Guidelines American College of Cardiology/American Heart Association/North American Society for Pacing and Electrophysiology Committee. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002 106 2145 2161.
4. Higgins SL Hummel JD Niazi IK Giudici MC Worley SJ Saxon LA Boehmer JP Higginbotham MB DeMarco T Foster E Yong PG Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003 42 454 459.
5. Stevenson WG Stevenson LW Prevention of sudden death in heart failure. J Cardiovasc Electrophysiol 2001 12 112 114.
6. Callans DF Josephson ME Ventricular tachycardia in patients with coronary artery disease. In: Zipes DP Jalife J eds Cardiac Electrophysiology: From Cell to Bedside. Fourth Edition. Philadelphia Saunders 2004 pp. 569 574.
7. Galvin JM Ruskin JN Ventricular tachycardia in patients with dilated cardiomyopathy. In: Zipes DP Jalife J eds. Cardiac Electrophysiology: From Cell to Bedside. Fourth Edition. Philadelphia Saunders 2004 pp. 575 587.
8. Whang W Mittleman MA Rich DQ Wang PJ Ruskin JN Tofler GH Muller JE Albert CM for the TOVA Investigators Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: Results from the Triggers Of Ventricular Arrhythmias Study. Circulation 2004 109 1386 1391.
9. Bardy GH Lee KL Mark DB Poole JE Packer DL Boineau R Domanski M Troutman C Anderson J Johnson G McNulty SE Clapp-Channing N Davidson-Ray LD Fraulo ES Fishbein DP Luceri RM Ip JH Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 225 237.
10. Kadish A Dyer A Daubert JP Quigg R Estes NA Anderson KP Calkins H Hoch D Goldberger J Shalaby A Sanders WE Schaechter A Levine JH Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004 350 2151 2158.
11. Wilkoff BL Hess M Young J Abraham WT Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 2004 15 1002 1009.
12. Klein RC Raitt MC Wilkoff BL Beckman KJ Coromilas J Wyse DG Friedman PL Martins JB Epstein AE Hallstrom AP Ledingham RB Belco KM Greene HL Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol 2003 14 940 948.
13. Moss AJ MADIT-II: Substudies and their implications. Cardiac Electrophysiol Rev 2003 7 430 433.
14. Sweeney MO Ruskin JN Mortality benefits and the implantable cardioverter-defibrillator. Circulation 1994 89 1851 1858.
15. Guarnieri T Levine JH Griffith LSC Veltri EP When "sudden cardiac death" is not so sudden: Lessons learned from the automatic implantable defibrillator. Am Heart J 1988 115 205 207.
16. http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=148.